Efficacy of dexpanthenol in skin protection against irritation:: a double-blind, placebo-controlled study

被引:48
|
作者
Biro, K [1 ]
Thaçi, D [1 ]
Ochsendorf, FR [1 ]
Kaufmann, R [1 ]
Boehncke, WH [1 ]
机构
[1] Goethe Univ Frankfurt, Dept Dermatol, D-60590 Frankfurt, Germany
关键词
corneometry; dermatitis; dexpanthenol; sebumetry; skin barrier; surface pH;
D O I
10.1111/j.0105-1873.2003.00184.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Dexpanthenol is popular in treating various dermatoses and in skin care, but few controlled clinical trials have been performed. We investigated the efficacy of dexpanthenol in skin protection against irritation in a randomized, prospective, double-blind, placebo-controlled study. 25 healthy volunteers (age 18-45 years) were treated for the inner aspect of both forearms with either Bepanthol((R)) Handbalsam containing 5% dexpanthenol or placebo x2 daily for 26 days. From day 15-22, sodium lauryl sulfate (SLS) 2% was applied to these areas x2 daily. Documentation comprised sebumetry, corneometry, pH value and clinical appearance (photographs). 21 volunteers completed the study, 3 were excluded because of non-compliance and 1 experienced a non-study-related, severe, adverse event. Only corneometry yielded a statistically significant difference, with decreased values following SLS challenge at the placebo sites (P < 0.05). Intraindividual comparisons showed superior results at the dexpanthenol-treated sites in 11 cases and in only 1 case at the placebo site. 6 volunteers experienced an irritant contact dermatitis, with more severe symptoms at the placebo site in 5 cases. In conclusion, dexpanthenol exhibits protective effects against skin irritation. The initiation of a study to evaluate the efficacy of dexpanthenol in preventing irritant occupational contact dermatitis under real workplace conditions is validated.
引用
收藏
页码:80 / 84
页数:5
相关论文
共 50 条
  • [41] A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling
    Kim, SW
    Grant, JE
    Adson, DE
    Shin, YC
    Zaninelli, R
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (06) : 501 - 507
  • [42] Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study
    Miyasaka, Nobuyuki
    Kawai, Shinichi
    Hashimoto, Hiroshi
    MODERN RHEUMATOLOGY, 2009, 19 (06) : 606 - 615
  • [43] Efficacy of sublingual immunotherapy in children with asthma and rhinitis:: A double-blind, placebo-controlled study
    Bahçeciler, NN
    Isik, U
    Barlan, IB
    Basaran, MM
    PEDIATRIC PULMONOLOGY, 2001, 32 (01) : 49 - 55
  • [44] Cidofovir efficacy in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled study
    McMurray, J. Scott
    Connor, Nadine
    Ford, Charles N.
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2008, 117 (07): : 477 - 483
  • [45] DOUBLE-BLIND PLACEBO-CONTROLLED EFFICACY STUDY OF KETAZOLAM (U-28,774)
    FABRE, LF
    HARRIS, RT
    STUBBS, DF
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1976, 4 (01) : 50 - 54
  • [46] Double-blind, placebo-controlled study of Alternaria alternata immunotherapy:: Clinical efficacy and safety
    Tabar, Ana I.
    Lizaso, Maria T.
    Garcia, Blanca E.
    Gomez, Belen
    Echechipia, Susana
    Aldunate, Maria T.
    Madariaga, BegonA
    Martinez, Alberto
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2008, 19 (01) : 67 - 75
  • [47] Efficacy and tolerability of Hairgain® in individuals with hair loss:: A placebo-controlled, double-blind study
    Thom, E
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2001, 29 (01) : 2 - 6
  • [48] Efficacy of agomelatine in generalized anxiety disorder: A randomized, double-blind, placebo-controlled study
    Stein, Dan J.
    Ahokas, Antti A.
    de Bodinat, Christian
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (05) : 561 - 566
  • [49] Double-blind, placebo-controlled study of quetiapine in bipolar depression
    Calabrese, JR
    Macfadden, W
    McCoy, R
    Minkwitz, M
    Wilson, E
    Mullen, J
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S92 - S92
  • [50] VIGABATRIN IN THE TREATMENT OF EPILEPSY - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    TARTARA, A
    MANNI, R
    GALIMBERTI, CA
    HARDENBERG, J
    ORWIN, J
    PERUCCA, E
    EPILEPSIA, 1986, 27 (06) : 717 - 723